Advances & Challenges in the Management of Obesity, MASH, and Related Complications (2025 Extended Access)

Only available as part of a package

Learning Objectives:

Critically appraise current and emerging pharmacologic and interventional therapies for obesity.
Critically appraise current and emerging pharmacologic and interventional therapies for metabolic dysfunction-associated steatohepatitis (MASH).
Identify ongoing challenges—including therapeutic access, adherence barriers, and disparities in care.

Andrew Buelt, DO

Hospitalist

Veterans Affairs Medical Center

Dr. Buelt graduated from Des Moines University and completed family medicine residency at in St. Petersburg, Florida. Currently he works as a Hospitalist at the Veterans Affairs Medical Center in Bay Pines, Fl and has worked as an Assistant Professor of Family Medicine at the University of Central Florida (UCF) College of Medicine and the Orlando College of Osteopathic Medicine.

Dr. Buelt has helped record and produce over 500 hours of continuous medical education.

Helping shape medical guidelines, Dr. Buelt co-authored guidelines on dyslipidemia, headaches, COPD, low back pain, stroke rehabilitation, and depression for the Veteran Affairs and Department of Defense. His prolific work extends to numerous Practice Guideline reviews in the Journal of American Family Physician. Beyond his written contributions, Dr. Buelt co-founded the globally recognized Questioning Medicine podcast, earning a spot on the American Family Physician list of "25 Podcast Episodes Every Family Physician Should Listen To." Dr. Buelt stands as a top-tier speaker, sharing unparalleled insight, expertise, in an evidence based perspective.

The faculty member, for this activity, has no relevant relationships with ineligible companies to disclose.